Related Experiment Video
Updated: Jun 27, 2025
13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
2.3K
Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne
Mana Murae1,2, Shota Sakai1, Non Miyata1
1Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases.
Biological & Pharmaceutical Bulletin
|May 1, 2024
Summary
A new compound, Nat-20(S)-yne, inhibits severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by blocking viral entry and decreasing cholesterol biosynthesis. This cholesterol derivative shows potential as a novel antiviral therapy for COVID-19.
Area of Science:
- Biochemistry
- Virology
- Drug Discovery
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, remains a global health threat requiring new antiviral treatments.
- Cholesterol derivatives, like 25-hydroxycholesterol, demonstrate antiviral properties against SARS-CoV-2.
- Viral entry involves the fusion of the viral envelope with host membranes, mediated by spike (S) glycoproteins.
Purpose of the Study:
- To identify novel cholesterol derivatives with antiviral activity against SARS-CoV-2.
- To investigate the mechanism of action of a newly identified compound, Nat-20(S)-yne, focusing on its effect on viral entry and replication.
Main Methods:
- Screening of cholesterol derivatives to identify compounds inhibiting SARS-CoV-2 S protein-mediated membrane fusion.
- Syncytium formation assays to evaluate inhibition of viral entry.
- In vitro assays using SARS-CoV-2 pseudoviruses and intact SARS-CoV-2 to assess dose-dependent inhibitory activity.
- Analysis of the effect on de novo cholesterol biosynthesis and plasma membrane cholesterol content.
Main Results:
- Nat-20(S)-yne was identified as an inhibitor of SARS-CoV-2 S protein-dependent membrane fusion.
- The compound demonstrated dose-dependent inhibition of SARS-CoV-2 pseudovirus entry and intact virus infection.
- Inhibition was more pronounced against Delta and Wuhan strains compared to Omicron strains, correlating with their cell entry mechanisms.
- Nat-20(S)-yne specifically inhibited de novo cholesterol biosynthesis, leading to reduced plasma membrane cholesterol and suppressed viral infection, without affecting the S protein-ACE2 interaction.
Conclusions:
- Nat-20(S)-yne represents a novel antiviral agent targeting SARS-CoV-2 entry via inhibition of cholesterol biosynthesis.
- Its unique mechanism of action suggests potential as a therapeutic candidate for COVID-19, particularly against strains entering via plasma membrane fusion.
Keywords:
26,27-dinorcholest-5-en-24-yne-3β,20-diol (Nat-20(S)-yne)antiviralcholesterolcholesterol biosynthesiscoronavirus disease 2019 (COVID-19)severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)More Related Videos
Related Concept Videos
01:30Enzyme Inhibition
78.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.3K
01:29Cholesterol: Significance and Regulation
540
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
540
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
555
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
555
01:45Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
01:52Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K